Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
US Army
Boehringer Ingelheim
Chubb
Covington
Federal Trade Commission
Daiichi Sankyo
Queensland Health
Teva
Cerilliant

Generated: August 23, 2017

DrugPatentWatch Database Preview

ZYRTEC HIVES RELIEF Drug Profile

« Back to Dashboard

Which patents cover Zyrtec Hives Relief, and what generic Zyrtec Hives Relief alternatives are available?

Zyrtec Hives Relief is a drug marketed by J And J Consumer Inc and is included in one NDA.

The generic ingredient in ZYRTEC HIVES RELIEF is cetirizine hydrochloride. There are thirty-nine drug master file entries for this compound. One hundred and sixty-two suppliers are listed for this compound. Additional details are available on the cetirizine hydrochloride profile page.

Summary for Tradename: ZYRTEC HIVES RELIEF

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list4
Bulk Api Vendors: see list49
Clinical Trials: see list2,045
Patent Applications: see list4,033
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ZYRTEC HIVES RELIEF at DailyMed

Pharmacology for Tradename: ZYRTEC HIVES RELIEF

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
J And J Consumer Inc
ZYRTEC HIVES RELIEF
cetirizine hydrochloride
TABLET;ORAL019835-005Nov 16, 2007OTCYesNo► Subscribe► Subscribe► Subscribe
J And J Consumer Inc
ZYRTEC HIVES RELIEF
cetirizine hydrochloride
TABLET;ORAL019835-006Nov 16, 2007OTCYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
Harvard Business School
Fish and Richardson
McKinsey
Novartis
Chinese Patent Office
Merck
US Department of Justice
Mallinckrodt
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot